首页> medRxiv : the preprint server for health sciences> Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

导出 LinkOut

翻译打印收藏纠错

第一作者： Niveditha,Ravindra

第一单位： Laboratory of Myeloid Malignancies, Hematology Branch, National Heart Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

作者： Niveditha,Ravindra ^[1] ; Laura W,Dillon ^[1] ; Gege,Gui ^[1] ; Matthew,Smith ^[2] ; Lukasz P,Gondek ^[2] ; Richard J,Jones ^[2] ; Adam,Corner ^[3] ; Christopher S,Hourigan ^[4] ; Alexander J,Ambinder ^[2]

作者单位： Laboratory of Myeloid Malignancies, Hematology Branch, National Heart Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. ^[1] Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. ^[2] Bio-Rad Laboratories, Digital Biology Group, 5731, W. Las Positias Blvd, Pleasanton, CA. ^[3] Laboratory of Myeloid Malignancies, Hematology Branch, National Heart Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.;Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD. ^[4]

DOI 10.1101/2023.08.14.23294087

PMID 37662423

发布时间 2025-07-24

基金项目

P01 CA225618/CA/NCI NIH HHS/United States P30 CA006973/CA/NCI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

medRxiv

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

检索历史清除

Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

medRxiv

相似文献

同项目论文

medRxiv

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Persistent <i>IDH</i> mutations are not associated with increased relapse or death in patients with <i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

medRxiv

相似文献

同项目论文

medRxiv

相关期刊

检索历史清除